Although its role in B cell-mediated tumor immunity remains insufficiently defined, the SIRT7–Pax5 axis may represent a possible mechanism of B cell regulation within the TME, with important implications for anti-cancer immunity. The gene discussed is PAX5; the disease is neoplasm.